Global Targeted Drug Delivery System 麻豆原创 Research Report 2023

Publication ID:

PB504236627

Publication Date:

April 5, 2023

Pages:

114

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Targeted Drug Delivery System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Targeted Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Targeted Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Targeted Drug Delivery System in First Order Targeting (Organ Compartmentalization) is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Targeted Drug Delivery System include 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis BiOthersapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc and Novartis Pharmaceuticals Corp, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Targeted Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drug Delivery System.
The Targeted Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Targeted Drug Delivery System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA
Segment by Type
Nano Tubes
Nano Wires
Nano Shells
Quantum Dots
Nano Pros
Segment by Application
First Order Targeting (Organ Compartmentalization)
Second Order Targeting (Cellular Targeting)
Third Order Targeting (Intracellular Targeting)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted Drug Delivery System companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Targeted Drug Delivery System 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Nano Tubes
1.2.3 Nano Wires
1.2.4 Nano Shells
1.2.5 Quantum Dots
1.2.6 Nano Pros
1.3 麻豆原创 by Application
1.3.1 Global Targeted Drug Delivery System 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 First Order Targeting (Organ Compartmentalization)
1.3.3 Second Order Targeting (Cellular Targeting)
1.3.4 Third Order Targeting (Intracellular Targeting)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Drug Delivery System 麻豆原创 Perspective (2018-2029)
2.2 Targeted Drug Delivery System Growth Trends by Region
2.2.1 Global Targeted Drug Delivery System 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Targeted Drug Delivery System Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Targeted Drug Delivery System Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Targeted Drug Delivery System 麻豆原创 Dynamics
2.3.1 Targeted Drug Delivery System Industry Trends
2.3.2 Targeted Drug Delivery System 麻豆原创 Drivers
2.3.3 Targeted Drug Delivery System 麻豆原创 Challenges
2.3.4 Targeted Drug Delivery System 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Drug Delivery System Players by Revenue
3.1.1 Global Top Targeted Drug Delivery System Players by Revenue (2018-2023)
3.1.2 Global Targeted Drug Delivery System Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Targeted Drug Delivery System 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted Drug Delivery System Revenue
3.4 Global Targeted Drug Delivery System 麻豆原创 Concentration Ratio
3.4.1 Global Targeted Drug Delivery System 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Drug Delivery System Revenue in 2022
3.5 Targeted Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Targeted Drug Delivery System Product Solution and Service
3.7 Date of Enter into Targeted Drug Delivery System 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Drug Delivery System Breakdown Data by Type
4.1 Global Targeted Drug Delivery System Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Targeted Drug Delivery System Forecasted 麻豆原创 Size by Type (2024-2029)
5 Targeted Drug Delivery System Breakdown Data by Application
5.1 Global Targeted Drug Delivery System Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Targeted Drug Delivery System Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Targeted Drug Delivery System 麻豆原创 Size (2018-2029)
6.2 North America Targeted Drug Delivery System 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Targeted Drug Delivery System 麻豆原创 Size by Country (2018-2023)
6.4 North America Targeted Drug Delivery System 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Drug Delivery System 麻豆原创 Size (2018-2029)
7.2 Europe Targeted Drug Delivery System 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Targeted Drug Delivery System 麻豆原创 Size by Country (2018-2023)
7.4 Europe Targeted Drug Delivery System 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Targeted Drug Delivery System 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Drug Delivery System 麻豆原创 Size (2018-2029)
9.2 Latin America Targeted Drug Delivery System 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Targeted Drug Delivery System 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Targeted Drug Delivery System 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Targeted Drug Delivery System 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M Company
11.1.1 3M Company Company Detail
11.1.2 3M Company Business Overview
11.1.3 3M Company Targeted Drug Delivery System Introduction
11.1.4 3M Company Revenue in Targeted Drug Delivery System Business (2018-2023)
11.1.5 3M Company Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Targeted Drug Delivery System Introduction
11.2.4 Abbott Laboratories Revenue in Targeted Drug Delivery System Business (2018-2023)
11.2.5 Abbott Laboratories Recent Development
11.3 Ablynx NV
11.3.1 Ablynx NV Company Detail
11.3.2 Ablynx NV Business Overview
11.3.3 Ablynx NV Targeted Drug Delivery System Introduction
11.3.4 Ablynx NV Revenue in Targeted Drug Delivery System Business (2018-2023)
11.3.5 Ablynx NV Recent Development
11.4 Aciont Inc
11.4.1 Aciont Inc Company Detail
11.4.2 Aciont Inc Business Overview
11.4.3 Aciont Inc Targeted Drug Delivery System Introduction
11.4.4 Aciont Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.4.5 Aciont Inc Recent Development
11.5 Acrux
11.5.1 Acrux Company Detail
11.5.2 Acrux Business Overview
11.5.3 Acrux Targeted Drug Delivery System Introduction
11.5.4 Acrux Revenue in Targeted Drug Delivery System Business (2018-2023)
11.5.5 Acrux Recent Development
11.6 Agilis BiOthersapeutics LLC
11.6.1 Agilis BiOthersapeutics LLC Company Detail
11.6.2 Agilis BiOthersapeutics LLC Business Overview
11.6.3 Agilis BiOthersapeutics LLC Targeted Drug Delivery System Introduction
11.6.4 Agilis BiOthersapeutics LLC Revenue in Targeted Drug Delivery System Business (2018-2023)
11.6.5 Agilis BiOthersapeutics LLC Recent Development
11.7 Aileron Therapeutics Inc
11.7.1 Aileron Therapeutics Inc Company Detail
11.7.2 Aileron Therapeutics Inc Business Overview
11.7.3 Aileron Therapeutics Inc Targeted Drug Delivery System Introduction
11.7.4 Aileron Therapeutics Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.7.5 Aileron Therapeutics Inc Recent Development
11.8 Nano Precision Medical Inc
11.8.1 Nano Precision Medical Inc Company Detail
11.8.2 Nano Precision Medical Inc Business Overview
11.8.3 Nano Precision Medical Inc Targeted Drug Delivery System Introduction
11.8.4 Nano Precision Medical Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.8.5 Nano Precision Medical Inc Recent Development
11.9 Novartis Pharmaceuticals Corp
11.9.1 Novartis Pharmaceuticals Corp Company Detail
11.9.2 Novartis Pharmaceuticals Corp Business Overview
11.9.3 Novartis Pharmaceuticals Corp Targeted Drug Delivery System Introduction
11.9.4 Novartis Pharmaceuticals Corp Revenue in Targeted Drug Delivery System Business (2018-2023)
11.9.5 Novartis Pharmaceuticals Corp Recent Development
11.10 Oxford Biomedica
11.10.1 Oxford Biomedica Company Detail
11.10.2 Oxford Biomedica Business Overview
11.10.3 Oxford Biomedica Targeted Drug Delivery System Introduction
11.10.4 Oxford Biomedica Revenue in Targeted Drug Delivery System Business (2018-2023)
11.10.5 Oxford Biomedica Recent Development
11.11 PharmaIN Corp
11.11.1 PharmaIN Corp Company Detail
11.11.2 PharmaIN Corp Business Overview
11.11.3 PharmaIN Corp Targeted Drug Delivery System Introduction
11.11.4 PharmaIN Corp Revenue in Targeted Drug Delivery System Business (2018-2023)
11.11.5 PharmaIN Corp Recent Development
11.12 PolyMicrospheres
11.12.1 PolyMicrospheres Company Detail
11.12.2 PolyMicrospheres Business Overview
11.12.3 PolyMicrospheres Targeted Drug Delivery System Introduction
11.12.4 PolyMicrospheres Revenue in Targeted Drug Delivery System Business (2018-2023)
11.12.5 PolyMicrospheres Recent Development
11.13 Presage Biosciences Inc
11.13.1 Presage Biosciences Inc Company Detail
11.13.2 Presage Biosciences Inc Business Overview
11.13.3 Presage Biosciences Inc Targeted Drug Delivery System Introduction
11.13.4 Presage Biosciences Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.13.5 Presage Biosciences Inc Recent Development
11.14 Pulmatrix Inc
11.14.1 Pulmatrix Inc Company Detail
11.14.2 Pulmatrix Inc Business Overview
11.14.3 Pulmatrix Inc Targeted Drug Delivery System Introduction
11.14.4 Pulmatrix Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.14.5 Pulmatrix Inc Recent Development
11.15 Quark Pharmaceuticals Inc
11.15.1 Quark Pharmaceuticals Inc Company Detail
11.15.2 Quark Pharmaceuticals Inc Business Overview
11.15.3 Quark Pharmaceuticals Inc Targeted Drug Delivery System Introduction
11.15.4 Quark Pharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.15.5 Quark Pharmaceuticals Inc Recent Development
11.16 RegeneRx Biopharmaceuticals Inc
11.16.1 RegeneRx Biopharmaceuticals Inc Company Detail
11.16.2 RegeneRx Biopharmaceuticals Inc Business Overview
11.16.3 RegeneRx Biopharmaceuticals Inc Targeted Drug Delivery System Introduction
11.16.4 RegeneRx Biopharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.16.5 RegeneRx Biopharmaceuticals Inc Recent Development
11.17 Replicor Inc
11.17.1 Replicor Inc Company Detail
11.17.2 Replicor Inc Business Overview
11.17.3 Replicor Inc Targeted Drug Delivery System Introduction
11.17.4 Replicor Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.17.5 Replicor Inc Recent Development
11.18 Rexahn Pharmaceuticals Inc
11.18.1 Rexahn Pharmaceuticals Inc Company Detail
11.18.2 Rexahn Pharmaceuticals Inc Business Overview
11.18.3 Rexahn Pharmaceuticals Inc Targeted Drug Delivery System Introduction
11.18.4 Rexahn Pharmaceuticals Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.18.5 Rexahn Pharmaceuticals Inc Recent Development
11.19 Roche Holding AG
11.19.1 Roche Holding AG Company Detail
11.19.2 Roche Holding AG Business Overview
11.19.3 Roche Holding AG Targeted Drug Delivery System Introduction
11.19.4 Roche Holding AG Revenue in Targeted Drug Delivery System Business (2018-2023)
11.19.5 Roche Holding AG Recent Development
11.20 Savara Inc
11.20.1 Savara Inc Company Detail
11.20.2 Savara Inc Business Overview
11.20.3 Savara Inc Targeted Drug Delivery System Introduction
11.20.4 Savara Inc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.20.5 Savara Inc Recent Development
11.21 Serina Therapeutics Inc.
11.21.1 Serina Therapeutics Inc. Company Detail
11.21.2 Serina Therapeutics Inc. Business Overview
11.21.3 Serina Therapeutics Inc. Targeted Drug Delivery System Introduction
11.21.4 Serina Therapeutics Inc. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.21.5 Serina Therapeutics Inc. Recent Development
11.22 Silenseed Ltd.
11.22.1 Silenseed Ltd. Company Detail
11.22.2 Silenseed Ltd. Business Overview
11.22.3 Silenseed Ltd. Targeted Drug Delivery System Introduction
11.22.4 Silenseed Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.22.5 Silenseed Ltd. Recent Development
11.23 SoluBest Ltd
11.23.1 SoluBest Ltd Company Detail
11.23.2 SoluBest Ltd Business Overview
11.23.3 SoluBest Ltd Targeted Drug Delivery System Introduction
11.23.4 SoluBest Ltd Revenue in Targeted Drug Delivery System Business (2018-2023)
11.23.5 SoluBest Ltd Recent Development
11.24 Suda Ltd
11.24.1 Suda Ltd Company Detail
11.24.2 Suda Ltd Business Overview
11.24.3 Suda Ltd Targeted Drug Delivery System Introduction
11.24.4 Suda Ltd Revenue in Targeted Drug Delivery System Business (2018-2023)
11.24.5 Suda Ltd Recent Development
11.25 Taiwan Liposome Co. Ltd.
11.25.1 Taiwan Liposome Co. Ltd. Company Detail
11.25.2 Taiwan Liposome Co. Ltd. Business Overview
11.25.3 Taiwan Liposome Co. Ltd. Targeted Drug Delivery System Introduction
11.25.4 Taiwan Liposome Co. Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.25.5 Taiwan Liposome Co. Ltd. Recent Development
11.26 Pipeline
11.26.1 Pipeline Company Detail
11.26.2 Pipeline Business Overview
11.26.3 Pipeline Targeted Drug Delivery System Introduction
11.26.4 Pipeline Revenue in Targeted Drug Delivery System Business (2018-2023)
11.26.5 Pipeline Recent Development
11.27 Vect-Horus S.A.S.
11.27.1 Vect-Horus S.A.S. Company Detail
11.27.2 Vect-Horus S.A.S. Business Overview
11.27.3 Vect-Horus S.A.S. Targeted Drug Delivery System Introduction
11.27.4 Vect-Horus S.A.S. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.27.5 Vect-Horus S.A.S. Recent Development
11.28 Vectura Group plc
11.28.1 Vectura Group plc Company Detail
11.28.2 Vectura Group plc Business Overview
11.28.3 Vectura Group plc Targeted Drug Delivery System Introduction
11.28.4 Vectura Group plc Revenue in Targeted Drug Delivery System Business (2018-2023)
11.28.5 Vectura Group plc Recent Development
11.29 WAVE Life Sciences Pvt. Ltd.
11.29.1 WAVE Life Sciences Pvt. Ltd. Company Detail
11.29.2 WAVE Life Sciences Pvt. Ltd. Business Overview
11.29.3 WAVE Life Sciences Pvt. Ltd. Targeted Drug Delivery System Introduction
11.29.4 WAVE Life Sciences Pvt. Ltd. Revenue in Targeted Drug Delivery System Business (2018-2023)
11.29.5 WAVE Life Sciences Pvt. Ltd. Recent Development
11.30 Xigen SA
11.30.1 Xigen SA Company Detail
11.30.2 Xigen SA Business Overview
11.30.3 Xigen SA Targeted Drug Delivery System Introduction
11.30.4 Xigen SA Revenue in Targeted Drug Delivery System Business (2018-2023)
11.30.5 Xigen SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

3M Company
Abbott Laboratories
Ablynx NV
Aciont Inc
Acrux
Agilis BiOthersapeutics LLC
Aileron Therapeutics Inc
Nano Precision Medical Inc
Novartis Pharmaceuticals Corp
Oxford Biomedica
PharmaIN Corp
PolyMicrospheres
Presage Biosciences Inc
Pulmatrix Inc
Quark Pharmaceuticals Inc
RegeneRx Biopharmaceuticals Inc
Replicor Inc
Rexahn Pharmaceuticals Inc
Roche Holding AG
Savara Inc
Serina Therapeutics Inc.
Silenseed Ltd.
SoluBest Ltd
Suda Ltd
Taiwan Liposome Co. Ltd.
Pipeline
Vect-Horus S.A.S.
Vectura Group plc
WAVE Life Sciences Pvt. Ltd.
Xigen SA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.